Discriminative disulfide-bonding affinity labeling of opioid receptor subtypes

Journal of Biochemical and Biophysical Methods

Volumn 49, Issue 1-3, 2001, Pages 587-606

  Shirasu, Naoto ^a   Shimohigashi, Yasuyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Affinity labeling; Disulfide bonding; Dynorphins; Enkephalins; Morphine; Opioid receptors; SNpys group

Indexed keywords

DIHYDROMORPHINE; DISULFIDE; DITHIOTHREITOL; DYNORPHIN; ENKEPHALIN; FUNCTIONAL GROUP; LIGAND; OPIATE RECEPTOR; RECEPTOR SUBTYPE; THIOL DERIVATIVE;

AFFINITY LABELING; ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; CROSS LINKING; DISULFIDE BOND; INCUBATION TIME; MALE; METHODOLOGY; MONITORING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

EID: 0035975912     PISSN: 0165022X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-022X(01)00222-6     Document Type: Review

References (60)

1. Structure of the agonist-binding sites of the Torpedo nicotinic acetylcholine receptor: Affinity-labeling and mutational analyses identify gamma Tyr-111/delta Arg-113 as antagonist affinity determinants
2. Probing the active site of alpha-class rat liver glutathione S-transferases using affinity labeling by monobromobimane
3. Affinity labeling displays the stepwise activation of ICE-related proteases by Fas, staurosporine, and CrmA-sensitive caspase-8
4. 3 receptor
5. The efficiency of covalent labeling of the pancreatic cholecystokinin receptor using a battery of crosslinkable and photolabile probes
6. Analysis of photoaffinity label derivatives to probe thyroid hormone receptor in human fibroblasts, GH1 cells, and soluble receptor preparations
7. 12 proteins
8. In situ photoaffinity labeling of proteasome with photoactive adriamycin analogue
9. Characterization of the interaction of zopiclone with gamma-aminobutyric acid type A receptors
10. 8]bradykinin is bound adjacent to analogous amino acids of the human and rat B2 receptor
11. Solubilization and characterization of a guanine nucleotide-sensitive form of the calcitonin gene-related peptide receptor
12. Solubilization and affinity purification of the Y2 receptor for neuropeptide Y and peptide YY from rabbit kidney
13. Cross-linking of endothelin 1 and endothelin 3 to rat brain membranes: Identification of the putative receptor(s)
14. Identification of a receptor for peptides of the bombesin family in Swiss 3T3 cells by affinity cross-linking
15. 3H-Tyr-D-Ala-Gly-(Me)Phe chloromethyl ketone
16. A novel electrophilic high-affinity irreversible probe for the cannabinoid receptor
17. 3 adenosine receptors
18. A peptide agonist acts by occupation of a monomeric G protein-coupled receptor: Dual sites of covalent attachment to domains near TM1 and TM7 of the same molecule make biologically significant domain-swapped dimerization unlikely
19. The sensitivity of opiate receptors and ligands to short wavelength ultraviolet light
20. Modification of the catalytic subunit of bovine heart cAMP-dependent protein kinase with affinity labels to peptides substrates
21. Design and synthesis of cathepsin B inhibitors by an affinity labeling approach
22. Activation of G protein-coupled receptors entails cysteine modulation of agonist binding
23. Structural insights into the aminoterminus of the secretin receptor: I. Status of cysteine and cystine residues
24. 2 receptor function and properties of two naturally occurring mutant receptors with additional extracellular cysteine residues
25. Palmitoylation occurs at cysteine 347 and cysteine 351 of the dopamine D(1) receptor
26. Identification and molecular characterization of m3 muscarinic receptor dimers
27. The cysteine of the cytoplasmic tail of glucose-dependent insulinotropic peptide receptor mediates its chronic desensitization and down-regulation
28. The high affinity state of the beta 2-adrenergic receptor requires unique interaction between conserved and non-conserved extracellular loop cysteines
29. Behavioural effects of opioid peptides
30. Circulating opioids: Possible physiological roles in central nervous function
31. The delta-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization
32. Cloning of a delta opioid receptor by functional expression
33. Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes
34. Cloning and functional comparison of kappa and delta opioid receptors from mouse brain
35. 3H]-etorphine to rat brain homogenate
36. Differential effects of protein-modifying reagents on receptor binding of opiate agonists and antagonists
37. Protection of opiate receptors in NG108-15 against modification by N-ethylmaleimide
38. Two different modifications of the neuroblastoma X glioma hybrid opiate receptors induced by N-ethylmaleimide
39. Design and synthesis of highly specific and selective enkephalin analog containing S-Npys-cysteine for delta opioid receptors
40. Discriminative affinity labeling of opioid receptors by enkephalin and morphiceptine analogues containing 3-nitro-2-pyridinesulphenyl-activated thiol residues
41. Reversible affinity labeling of opioid receptors via disulfide bonding: Discriminative labeling of mu and delta subtypes by chemically activated thiol-containing enkephalin analogs
42. Exploration of universal cysteines in the binding sites of three opioid receptor subtypes by disulfide-bonding affinity labeling with chemically activated thiol-containing dynorphin A analogs
43. The effects of adrenaline, noradrenaline and isoprenaline on inhibitory alpha- and beta-adrenoceptors in the longitudinal muscle of the guinea-pig ileum
44. Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antagonist potencies of narcotic analgesics
45. A potent peptide affinity reagent for the opiate receptor
46. Specificity of the opioid affinity reagent, DALECK, in a set of isolated tissue assay system
47. Irreversible labelling of rat brain opioid receptors by enkephalin chloromethyl ketones
48. Tyr-D-Ala-Gly-(Me)Phe-chloromethyl ketone: A mu specific affinity label for the opioid receptor
49. Molecular model building of multiple opioid receptor subtypes
50. Ligand recognition in mu opioid receptor: Experimentally based modeling of mu opioid receptor binding sites and their testing by ligand docking
51. Dynorphin is a specific endogenous ligand of the kappa opioid receptor
52. Dynorphin 1-8 and dynorphin 1-9 are ligands for the kappa-subsite of opioid receptor
53. Opioid peptides and their receptors
54. A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation
55. Dimerization of the delta opioid receptor: Implication for a role in receptor internalization
56. Oligomerization of dopamine and serotonin receptors
57. Domain swapping in G-protein coupled receptor dimers
58. Metabotoropic glutamate receptor 5 is a disulfide-linked dimer
59. Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells
60. G-protein-coupled receptor heterodimerization modulates receptor function